COMP <GO>
ZJYL vs UNH // RSI-14 & 200D SMA MOMENTUM
JIN MEDICAL INTERNATIONAL LTD. (Class A) (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: ZJYL 1
— UNH 9
▲ RSI-14 & 200D SMA MOMENTUM LEADER: UNH
LAST: $1.86 (-2.10%) • MKT CAP: $294.2M
rsi-technicals
44.3
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
rsi-technicals
59.2
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ZJYL VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ZJYL | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 29.20% | 88.57% | -59.37 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | 11.47% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 47.1x | 16.4x | +30.65 | UNH | /valuation <GO> |
| Free Cash Flow Yield | -1.27% | 6.48% | -7.75 | UNH | /fcf-yield <GO> |
| Operating Margin | 2.90% | 4.82% | -1.92 | UNH | /operating-margins <GO> |
| Net Profit Margin | 5.80% | 3.14% | +2.66 | ZJYL | /net-margins <GO> |
| Revenue Growth (YoY) | -12.00% | 6.46% | -18.46 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 3.12 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 44.3 | 59.2 | -14.90 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 17.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $294.2M | $368.83B | -$368.54B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ZJYL REV | UNH REV | ZJYL GROSS % | UNH GROSS % | ZJYL FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $20.7M | $447.57B | 29.2% | 88.7% | -$3.7M | $16.07B |
| FY 2024 | $23.5M | $400.28B | 40.4% | 88.3% | -$1.4M | $20.70B |
| FY 2023 | $19.8M | $371.62B | — | 89.6% | $3.1M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ZJYL // BETA —
UNH // BETA 0.33